129 related articles for article (PubMed ID: 29157672)
41. Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13.
Kehrmann A; Truong H; Repenning A; Boger R; Klein-Hitpass L; Pascheberg U; Beckmann A; Opalka B; Kleine-Lowinski K
Cancer Genet; 2013; 206(7-8):279-92. PubMed ID: 24042169
[TBL] [Abstract][Full Text] [Related]
42. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
43. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
44. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
45. A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growth.
Fernandez-Zapico ME; Lomberk GA; Tsuji S; DeMars CJ; Bardsley MR; Lin YH; Almada LL; Han JJ; Mukhopadhyay D; Ordog T; Buttar NS; Urrutia R
Biochem J; 2011 Apr; 435(2):529-37. PubMed ID: 21171965
[TBL] [Abstract][Full Text] [Related]
46. HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.
Das M; Prasad SB; Yadav SS; Modi A; Singh S; Pradhan S; Narayan G
Tumour Biol; 2015 Dec; 36(12):9987-94. PubMed ID: 26188903
[TBL] [Abstract][Full Text] [Related]
47. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
48. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
49. [Effect of Hydralazine on demethylation status and expression of APC gene, proliferation and apoptosis of human cervical cancer cell lines].
Song YH; Zhang CJ
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):614-8. PubMed ID: 18070451
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
51. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
52. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
53. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
54. Ectonucleotidase expression profile and activity in human cervical cancer cell lines.
Beckenkamp A; Santana DB; Bruno AN; Calil LN; Casali EA; Paccez JD; Zerbini LF; Lenz G; Wink MR; Buffon A
Biochem Cell Biol; 2014 Apr; 92(2):95-104. PubMed ID: 24697693
[TBL] [Abstract][Full Text] [Related]
55. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
56. Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.
Kontostathi G; Zoidakis J; Makridakis M; Lygirou V; Mermelekas G; Papadopoulos T; Vougas K; Vlamis-Gardikas A; Drakakis P; Loutradis D; Vlahou A; Anagnou NP; Pappa KI
Biomed Res Int; 2017; 2017():4180703. PubMed ID: 28261610
[TBL] [Abstract][Full Text] [Related]
57. A Krüppel-like factor in Caenorhabditis elegans with essential roles in fat regulation, cell death, and phagocytosis.
Hashmi S; Ji Q; Zhang J; Parhar RS; Huang CH; Brey C; Gaugler R
DNA Cell Biol; 2008 Oct; 27(10):545-51. PubMed ID: 18680432
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
59. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus (HPV) oncoprotein E6 facilitates Calcineurin-Nuclear factor for activated T cells 2 (NFAT2) signaling to promote cellular proliferation in cervical cell carcinoma.
Ram BM; Dolpady J; Kulkarni R; Usha R; Bhoria U; Poli UR; Islam M; Trehanpati N; Ramakrishna G
Exp Cell Res; 2018 Jan; 362(1):132-141. PubMed ID: 29129565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
